RE:Anyone buying down here (not a joke)It's a good buy apart from the possible temporary Egrifta shortage f,,up. I'm bracing for a title like: Thera revenu drops 80% in Q1 from local papers but maybe the FDA can go go trough before shortage once they file for PSA thing. Pretty unreal you have to resubmit your drug batches for approval even tought nothing was wrong with the drug to start with.